康弘药业 - Financials

康弘药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009
+Revenue	4.5B	4.0B	3.4B	3.6B	3.3B	3.3B	2.9B	2.8B	2.5B	2.1B	1.7B	1.5B	1.3B	1.0B	796.0M	638.0M
Revenue Growth %	12.5%	16.8%	-6.0%	9.4%	1.2%	11.7%	4.7%	9.7%	22.5%	23.8%	13.4%	11.0%	30.9%	27.8%	24.8%	--
Total Revenue	4.5B	4.0B	3.4B	3.6B	3.3B	3.3B	2.9B	2.8B	2.5B	2.1B	1.7B	1.5B	1.3B	1.0B	796.0M	638.0M
Cost Of Revenue	466.0M	438.0M	388.0M	355.0M	330.0M	264.0M	229.0M	269.0M	244.0M	226.0M	193.0M	171.0M	157.0M	115.0M	84.0M	67.4M
+Gross Profit	4.0B	3.5B	3.0B	3.2B	3.0B	3.0B	2.7B	2.5B	2.3B	1.8B	1.5B	1.3B	1.2B	902.0M	712.0M	570.6M
Gross Margin %	89.5%	88.9%	88.6%	90.2%	90.0%	91.9%	92.1%	90.3%	90.4%	89.1%	88.5%	88.4%	88.2%	88.7%	89.4%	89.4%
Total Operating Cost	3.2B	2.8B	2.5B	3.4B	3.9B	2.5B	2.2B	2.1B	2.0B	1.6B	1.4B	1.2B	1.1B	816.0M	661.0M	528.0M
Selling Expenses	1.6B	1.5B	1.3B	1.4B	1.4B	1.6B	1.4B	1.3B	1.3B	1.1B	871.0M	713.0M	651.0M	486.0M	389.0M	298.0M
Admin Expenses	471.0M	472.0M	390.0M	382.0M	485.0M	403.0M	386.0M	312.0M	387.0M	306.0M	270.0M	268.0M	242.0M	193.0M	169.0M	154.0M
Rd Expenses	580.0M	422.0M	374.0M	1.0B	1.7B	287.0M	230.0M	192.0M	--	--	--	--	--	--	--	--
Finance Expenses	-62.3M	-52.4M	-44.9M	-34.3M	-27.0M	-30.7M	-46.0M	-30.3M	-24.1M	-15.6M	-8.2M	-3.4M	1.3M	2.7M	1.6M	-2.2M
+Operating Income	1.4B	1.3B	1.0B	355.0M	-512.0M	821.0M	796.0M	788.0M	551.0M	438.0M	330.0M	353.0M	219.0M	178.0M	124.0M	104.0M
Operating Margin %	31.0%	31.9%	29.9%	9.8%	-15.5%	25.2%	27.3%	28.3%	21.7%	21.1%	19.7%	23.9%	16.5%	17.5%	15.6%	16.3%
Non Operating Income	5.4M	1.4M	26.4M	56.8M	45.4M	45.3M	34.1M	20.2M	35.3M	32.1M	23.0M	26.6M	35.6M	29.1M	16.1M	5.9M
Non Operating Expenses	34.2M	28.5M	11.5M	18.6M	52.6M	30.9M	30.8M	44.7M	18.7M	13.5M	15.0M	7.1M	3.9M	2.0M	2.5M	6.1M
Investment Income	47.3M	45.0M	38.1M	26.4M	34.1M	23.3M	28.4M	30.0M	15.6M	11.4M	11.2M	51.8M	-35.6M	-22.4M	-11.0M	-5.8M
Fair Value Change Income	-1.1M	-832,800	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Asset Disposal Income	14,200	9,000	--	--	--	--	-53,300	-28.7M	-5.5M	--	--	--	--	--	--	--
Asset Impairment Loss	2.8M	230,500	4.1M	216.0M	506,700	892,000	4.7M	5.5M	1.1M	891,900	1.5M	451,100	2.1M	2.2M	4.9M	1.1M
Other Income	44.5M	68.0M	68.1M	102.0M	74.1M	74.5M	73.6M	73.2M	--	--	--	--	--	--	--	--
Income Before Tax	1.4B	1.2B	1.0B	393.0M	-520.0M	835.0M	799.0M	763.0M	568.0M	456.0M	338.0M	372.0M	251.0M	205.0M	137.0M	104.0M
Income Tax	176.0M	203.0M	164.0M	-27.7M	-250.0M	117.0M	105.0M	119.0M	67.6M	59.4M	61.2M	53.3M	45.1M	37.7M	28.8M	21.4M
+Net Income	1.2B	1.0B	866.0M	421.0M	-270.0M	718.0M	695.0M	644.0M	500.0M	397.0M	276.0M	319.0M	206.0M	168.0M	109.0M	82.4M
Net Margin %	26.4%	26.1%	25.6%	11.7%	-8.2%	22.0%	23.8%	23.1%	19.7%	19.1%	16.5%	21.6%	15.5%	16.5%	13.7%	12.9%
Net Income Attributable	1.2B	1.0B	897.0M	421.0M	-270.0M	718.0M	695.0M	644.0M	497.0M	394.0M	273.0M	316.0M	203.0M	165.0M	109.0M	82.4M
Minority Interest	-14.2M	-13.6M	-30.9M	-3,800	--	--	--	--	3.4M	3.2M	3.0M	3.4M	3.0M	2.6M	--	--
Eps Basic	1.30	1.14	0.98	0.46	-0.31	0.82	0.80	0.96	0.74	0.62	0.68	0.79	0.51	0.43	0.33	0.25
Eps Diluted	1.30	1.14	0.98	0.46	-0.31	0.82	0.80	0.95	0.74	0.62	0.68	--	--	0.43	0.33	0.25

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009
Cash And Equivalents	5.7B	4.7B	3.6B	2.9B	3.3B	2.3B	2.5B	3.1B	2.4B	1.7B	946.0M	746.0M	484.0M	340.0M	205.0M	186.0M
Trading Financial Assets	--	--	100.0M	200.0M	--	--	--	--	--	--	--	--	--	--	--	--
Accounts Receivable	177.0M	160.0M	150.0M	183.0M	330.0M	393.0M	259.0M	167.0M	65.4M	85.2M	91.1M	76.1M	73.6M	66.8M	59.9M	50.9M
Notes Receivable	371,100	--	11.1M	21.4M	15.8M	41.4M	157.0M	3.9M	1.8M	2.3M	9.5M	--	6.3M	2.7M	1.9M	665,200
Notes And Accounts Receivable	178.0M	160.0M	161.0M	205.0M	346.0M	434.0M	415.0M	171.0M	67.2M	87.5M	101.0M	76.1M	79.9M	69.5M	61.9M	51.5M
Prepayments	11.5M	10.5M	24.0M	15.8M	22.6M	29.9M	26.6M	13.9M	7.0M	17.4M	31.6M	12.1M	20.5M	24.4M	23.0M	89.5M
Inventory	387.0M	404.0M	331.0M	296.0M	240.0M	263.0M	254.0M	174.0M	147.0M	113.0M	105.0M	80.2M	85.4M	67.9M	44.4M	34.4M
Total Current Assets	6.3B	5.3B	4.2B	3.7B	4.0B	3.0B	3.4B	3.5B	2.9B	2.1B	1.2B	917.0M	672.0M	508.0M	343.0M	392.0M
Long Term Equity Investment	16.4M	16.8M	17.0M	17.7M	18.4M	8.8M	9.5M	--	--	--	--	--	94.9M	131.0M	174.0M	134.0M
Fixed Assets	--	2.2B	2.1B	1.3B	--	733.0M	442.0M	436.0M	409.0M	426.0M	458.0M	486.0M	548.0M	407.0M	183.0M	134.0M
Fixed Assets Total	2.2B	2.2B	2.1B	1.3B	1.2B	733.0M	442.0M	436.0M	409.0M	426.0M	458.0M	486.0M	548.0M	407.0M	183.0M	134.0M
Construction In Progress	--	167.0M	476.0M	809.0M	607.0M	540.0M	398.0M	228.0M	129.0M	74.6M	27.6M	10.7M	6.6M	79.7M	171.0M	39.1M
Construction In Progress Total	112.0M	167.0M	476.0M	809.0M	607.0M	540.0M	398.0M	228.0M	129.0M	74.6M	27.6M	10.7M	6.6M	79.7M	171.0M	39.1M
Intangible Assets	287.0M	317.0M	331.0M	278.0M	294.0M	319.0M	275.0M	179.0M	159.0M	163.0M	156.0M	166.0M	98.4M	101.0M	105.0M	110.0M
Long Term Deferred Expenses	6.4M	7.2M	8.5M	11.0M	2.3M	3.5M	4.2M	7.8M	14.9M	22.1M	13.1M	7.7M	3.9M	2.3M	2.1M	291,100
Total Non Current Assets	3.1B	3.2B	3.5B	3.3B	3.0B	2.8B	1.8B	1.1B	882.0M	760.0M	752.0M	778.0M	840.0M	787.0M	648.0M	431.0M
Total Assets	9.3B	8.5B	7.7B	7.0B	7.0B	5.8B	5.2B	4.6B	3.8B	2.9B	1.9B	1.7B	1.5B	1.3B	991.0M	823.0M
Short Term Borrowings	--	--	--	--	--	--	--	--	--	--	5.0M	5.0M	40.0M	55.0M	60.0M	--
Accounts Payable	297.0M	344.0M	410.0M	343.0M	289.0M	240.0M	102.0M	127.0M	73.6M	38.6M	33.0M	39.0M	62.1M	55.2M	24.7M	21.1M
Advance Receipts	4.6M	3.9M	2.0M	4.8M	6.6M	18.2M	18.9M	10.2M	13.7M	5.1M	2.1M	2.9M	4.3M	1.9M	1.8M	1.5M
Contract Liabilities	8.9M	5.1M	9.1M	8.4M	11.8M	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	655.0M	654.0M	694.0M	667.0M	980.0M	747.0M	620.0M	579.0M	593.0M	281.0M	231.0M	209.0M	266.0M	266.0M	281.0M	212.0M
Long Term Borrowings	--	--	--	--	--	--	--	--	--	--	--	--	2.0M	2.0M	--	--
Total Non Current Liabilities	40.1M	63.3M	120.0M	184.0M	266.0M	459.0M	491.0M	463.0M	261.0M	95.4M	98.3M	96.4M	110.0M	93.5M	84.9M	71.5M
Total Liabilities	695.0M	718.0M	814.0M	851.0M	1.2B	1.2B	1.1B	1.0B	853.0M	376.0M	329.0M	306.0M	375.0M	360.0M	366.0M	284.0M
Paid In Capital	920.0M	919.0M	919.0M	919.0M	919.0M	874.0M	674.0M	674.0M	675.0M	446.0M	400.0M	360.0M	360.0M	360.0M	150.0M	150.0M
Capital Reserve	2.0B	2.0B	2.0B	2.0B	2.0B	377.0M	621.0M	646.0M	632.0M	674.0M	143.0M	183.0M	183.0M	183.0M	10.9M	10.9M
Surplus Reserve	515.0M	515.0M	481.0M	460.0M	356.0M	333.0M	313.0M	284.0M	246.0M	216.0M	187.0M	163.0M	135.0M	121.0M	111.0M	102.0M
Retained Earnings	5.2B	4.4B	3.5B	2.7B	2.5B	3.0B	2.5B	2.0B	1.5B	1.2B	862.0M	666.0M	414.0M	262.0M	345.0M	277.0M
Minority Equity	-6.3M	7.9M	5.1M	15.2M	--	--	--	--	--	23.2M	20.1M	17.1M	43.7M	10.6M	8.0M	--
Equity Attributable	8.7B	7.8B	6.9B	6.1B	5.8B	4.6B	4.1B	3.5B	2.9B	2.5B	1.6B	1.4B	1.1B	926.0M	617.0M	540.0M
Total Equity	8.6B	7.8B	6.9B	6.1B	5.8B	4.6B	4.1B	3.5B	2.9B	2.5B	1.6B	1.4B	1.1B	936.0M	625.0M	540.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009
Cash From Sales	4.8B	4.3B	3.7B	4.1B	3.6B	3.6B	3.0B	3.1B	2.9B	2.4B	1.9B	1.7B	1.5B	1.2B	886.0M	741.0M
Tax Refunds Received	2.6M	30.5M	66.0M	30.6M	11.8M	--	--	--	--	--	--	--	--	--	--	--
Total Operating Cash Inflow	4.8B	4.4B	3.8B	4.2B	3.7B	3.7B	3.2B	3.4B	3.1B	2.4B	2.0B	1.8B	1.6B	1.2B	946.0M	790.0M
Cash Paid For Goods	372.0M	337.0M	280.0M	287.0M	205.0M	203.0M	249.0M	286.0M	173.0M	134.0M	131.0M	115.0M	139.0M	89.2M	70.4M	48.2M
Cash Paid To Employees	1.2B	1.0B	974.0M	974.0M	914.0M	929.0M	768.0M	664.0M	509.0M	417.0M	353.0M	306.0M	252.0M	187.0M	148.0M	118.0M
Taxes Paid	403.0M	422.0M	410.0M	481.0M	475.0M	440.0M	473.0M	490.0M	446.0M	399.0M	348.0M	308.0M	299.0M	199.0M	162.0M	148.0M
Total Operating Cash Outflow	3.4B	3.1B	2.9B	3.7B	3.5B	2.9B	2.8B	2.6B	2.3B	2.0B	1.7B	1.4B	1.3B	1.0B	810.0M	681.0M
Operating Cash Flow	1.4B	1.2B	925.0M	494.0M	273.0M	812.0M	351.0M	767.0M	846.0M	482.0M	291.0M	333.0M	282.0M	169.0M	137.0M	108.0M
Total Investing Cash Inflow	4.4B	4.7B	5.8B	4.1B	6.0B	2.2B	2.7B	3.6B	2.9B	3.0B	2.3B	819.0M	298.0M	154.0M	43.5M	452.0M
Total Investing Cash Outflow	4.5B	4.7B	6.0B	4.9B	6.6B	3.0B	3.4B	3.5B	3.1B	3.3B	2.3B	815.0M	381.0M	302.0M	208.0M	622.0M
Investing Cash Flow	-112.0M	6.6M	-216.0M	-803.0M	-584.0M	-794.0M	-756.0M	75.8M	-250.0M	-262.0M	-34.4M	3.2M	-82.8M	-149.0M	-164.0M	-170.0M
Cash From Borrowings	--	--	--	--	7.7M	--	--	--	--	--	5.0M	5.0M	40.0M	57.0M	106.0M	50.0M
Dividends And Interest Paid	349.0M	138.0M	91.9M	91.9M	245.0M	188.0M	189.0M	101.0M	89.1M	60.1M	54.3M	37.4M	39.7M	141.0M	25.0M	16.0M
Debt Repayments	--	--	--	--	7.7M	--	--	--	--	5.0M	7.0M	40.0M	55.0M	60.0M	35.0M	70.0M
Total Financing Cash Inflow	6.7M	9.4M	20.7M	15.2M	1.6B	--	--	--	187.0M	592.0M	5.0M	5.0M	40.0M	318.0M	106.0M	50.0M
Total Financing Cash Outflow	351.0M	140.0M	94.5M	94.1M	257.0M	230.0M	205.0M	123.0M	89.1M	70.9M	62.4M	78.6M	95.4M	203.0M	60.0M	86.0M
Financing Cash Flow	-344.0M	-130.0M	-73.9M	-78.8M	1.4B	-230.0M	-205.0M	-123.0M	97.9M	521.0M	-57.4M	-73.6M	-55.4M	115.0M	46.3M	-36.0M
Net Change In Cash	955.0M	1.1B	637.0M	-389.0M	1.0B	-209.0M	-608.0M	715.0M	698.0M	742.0M	199.0M	262.0M	144.0M	135.0M	18.7M	-97.8M
Ending Cash Balance	5.6B	4.7B	3.6B	2.9B	3.3B	2.3B	2.5B	3.1B	2.4B	1.7B	946.0M	746.0M	484.0M	340.0M	205.0M	186.0M
Capex	159.0M	139.0M	355.0M	569.0M	617.0M	963.0M	458.0M	313.0M	170.0M	116.0M	90.3M	77.2M	130.0M	157.0M	132.0M	158.0M